Agreements reached under this partnership
Business Alliance- 1
BIOLAB will manufacture and supply iHEAL brand products.
- 2
AIDEN will handle import coordination.
- 3
ジェリービーンズ has obtained the exclusive rights to distribute and market iHEAL brand products in Japan and will serve as the exclusive distributor in Japan.
- 4
The products may be sold in Japan through directly operated stores, wholesale channels and online.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The brand is expected to contribute to higher sales and profit, but its contribution has not been incorporated into the full-year earnings forecast. The impact of this matter on full-year results is currently being examined, and if an impact arises, it will be disclosed promptly.
| Item | Details |
|---|---|
| Name of alliance partner | AIDEN LAB JAPAN Co., Ltd., BIOLAB Corp. |
| Alliance partner's business activities | Import, marketing and brand development of apparel products, Research and manufacture of femcare lactic acid bacteria products, and development of the iHEAL brand |
| Alliance partner's location | Shibuya, Tokyo, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea |
| Alliance partner's capital | ¥1 million, ¥1,400 million |
| Alliance partner's net sales | Not disclosed at the request of the counterparty. |
| Alliance partner's operating income | Not disclosed at the request of the counterparty. |
| Type of alliance | Business Alliance |
| Details of the alliance | BIOLAB will manufacture and supply iHEAL brand products., AIDEN will handle import coordination., ジェリービーンズ has obtained the exclusive rights to distribute and market iHEAL brand products in Japan and will serve as the exclusive distributor in Japan., The products may be sold in Japan through directly operated stores, wholesale channels and online. |
| Date of board resolution | 18 June 2026 |
| Contract Date | 18 June 2026 |
| Alliance start date | Full-scale sales are scheduled to begin in the second half of the fiscal year ending January 2027. |
| Impact on Business Performance | The brand is expected to contribute to higher sales and profit, but its contribution has not been incorporated into the full-year earnings forecast. The impact of this matter on full-year results is currently being examined, and if an impact arises, it will be disclosed promptly. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To develop the Japanese market by leveraging the Company's personnel, brand recognition and network in the women's footwear business, while capitalizing on synergies with a popular Korean brand.